MAPK3 and cancer: Apigenin was discovered to cause the death of cancer cells and diminish cancer cell survival in human choriocarcinoma cells by inhibiting the AKT-mTOR pathway and by boosting the phosphorylation of ERK1/2 and P90RSK in an appropriate dose-dependent manner [107].